Cargando…
Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role
BACKGROUND: Polycomb group (PcG) proteins are histone modifiers known to transcriptionally silence key tumour suppressor genes in multiple human cancers. The chromobox proteins (CBX2, 4, 6, 7, and 8) are critical components of PcG-mediated repression. Four of them have been associated with tumour bi...
Autores principales: | Clermont, P-L, Sun, L, Crea, F, Thu, K L, Zhang, A, Parolia, A, Lam, W L, Helgason, C D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200100/ https://www.ncbi.nlm.nih.gov/pubmed/25225902 http://dx.doi.org/10.1038/bjc.2014.474 |
Ejemplares similares
-
Genotranscriptomic meta‐analysis of the CHD family chromatin remodelers in human cancers – initial evidence of an oncogenic role for CHD7
por: Chu, Xiaofang, et al.
Publicado: (2017) -
Polycomb-mediated silencing in neuroendocrine prostate cancer
por: Clermont, Pier-Luc, et al.
Publicado: (2015) -
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer
por: Clermont, Pier-Luc, et al.
Publicado: (2016) -
Age-related changes in polycomb gene regulation disrupt lineage fidelity in intestinal stem cells
por: Tauc, Helen M, et al.
Publicado: (2021) -
Identification of 33 candidate oncogenes by screening for base-specific mutations
por: Tuupanen, S, et al.
Publicado: (2014)